Sandipkumar S. Kapadia
Director of Finance/CFO en HARMONY BIOSCIENCES HOLDINGS, INC. .
Fortuna: - $ al 31/03/2024
Origen de la red de primer grado Sandipkumar S. Kapadia.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Biotechnology | 32 | |
| Public Company | Pharmaceuticals: Major | 25 | |
| Public Company | Pharmaceuticals: Major | 23 | |
| Public Company | Biotechnology | 22 | |
| Extinct | Pharmaceuticals: Major | 14 | |
Molecular Partners, Inc.
 Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The private company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
VectivBio AG
 VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland.
8
| Subsidiary | Biotechnology | 8 |
Therachon Holding GmbH
 Therachon Holding GmbH BiotechnologyHealth Technology Therachon Holding GmbH engages in the acquisition, management, financing, and disposal of participating interests in firms. It also acquires, holds, and disposes intellectual property rights. The company was founded on December 22, 2015 and is headquartered in Basel, Switzerland.
5
| Subsidiary | Biotechnology | 5 |
Intercept Pharma Europe Ltd.
 Intercept Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Intercept Pharma Europe Ltd. is a subsidiary of Intercept Pharmaceuticals, Inc. that researches, develops, and sells pharmaceutical products. The private company is based in Bristol, UK.
3
| Subsidiary | Miscellaneous Commercial Services | 3 |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Sandipkumar S. Kapadia a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Corporate Officer/Principal | |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Analyst Private Equity Investor Consultant / Advisor | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Chairman Corporate Officer/Principal Corporate Officer/Principal | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| CHIMERIX, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Cerexa, Inc.
 Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Founder Director/Board Member Director/Board Member | |
| SHIRE | Pharmaceuticals: Major | Director/Board Member Public Communications Contact Compliance Officer | |
| RHYTHM PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| COGENT BIOSCIENCES, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer General Counsel | |
| University of Pennsylvania | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) MiscellaneousMiscellaneous Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Miscellaneous | Consultant / Advisor Corporate Officer/Principal Corporate Officer/Principal | |
| Imperial College London | College/University | Corporate Officer/Principal Undergraduate Degree | |
| McGill University | College/University | Undergraduate Degree Undergraduate Degree | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer Director/Board Member | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
| University of Michigan | College/University | Masters Business Admin Doctorate Degree | |
The Aspen Institute, Inc.
 The Aspen Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The Aspen Institute operates an institution that fosters leadership skills and open-minded dialogue. It conducts seminars, policy programs, conferences and leadership development initiatives, the Institute and its international partners seek to promote nonpartisan inquiry. The company was founded in 1949 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Corporate Secretary | |
| University of Zurich | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| Swiss Federal Institute of Technology | College/University | Graduate Degree Corporate Officer/Principal Undergraduate Degree | |
| University of Bern | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Masters Business Admin | |
The Commercial Club of Chicago
 The Commercial Club of Chicago Miscellaneous Commercial ServicesCommercial Services The Commercial Club of Chicago works to shape the future of the region to make it a better place for everyone to live, work, and do business. The non-profit company is based in Chicago, IL. The company's civic committee has announced violence reduction goals and commitments to help address public safety. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
Lundbeck, Inc.
 Lundbeck, Inc. Pharmaceuticals: MajorHealth Technology Part of Lundbeck Foundation, Lundbeck, Inc. is a pharmaceutical company that produces pharmaceutical preparations. The private company is based in Paramus, NJ. The company was founded by Jeffrey S. Aronin. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
Addepar, Inc.
 Addepar, Inc. Packaged SoftwareTechnology Services Addepar, Inc. provides platform for wealth management. Its solutions include RIA, family office, private bank, broker-dealer, and integrations. The company was founded by Jason Mirra and Joseph Lonsdale in 2009 and is headquartered in Mountain View, CA. | Packaged Software | Director/Board Member Director/Board Member | |
| AUDENTES THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Chief Tech/Sci/R&D Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree Masters Business Admin Undergraduate Degree | |
| VAXCYTE, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Therachon SAS
 Therachon SAS BiotechnologyHealth Technology TherAchon SAS provides biotechnology services. It specializes in research and development for achondroplasia and its associated complications. The company was founded by Elvire Gouze in 2014 and is headquartered in Biot, France. | Biotechnology | Chairman Director/Board Member Chief Executive Officer | |
| ARVINAS, INC. | Biotechnology | Director/Board Member Director/Board Member General Counsel | |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Financial Conglomerates | Director/Board Member Corporate Officer/Principal | |
Harmony Biosciences LLC
 Harmony Biosciences LLC Pharmaceuticals: MajorHealth Technology Harmony Biosciences LLC operates as a biopharmaceutical company which develops therapies to help patients with unmet medical needs. It provides novel treatment options to patients with orphan and rare conditions, with an emphasis on central nervous system disorders. The company is headquartered in Plymouth Meeting, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
Scout Bio, Inc.
 Scout Bio, Inc. Pharmaceuticals: MajorHealth Technology Scout Bio, Inc. operates as a biotechnology company that focuses on the innovation of pet medicine by delivering a pipeline of one-time therapeutics for major chronic pet health conditions. It also specializes in gene therapy, veterinary product development and biotechnology investment. The company was founded by James M. Wilson in 2016 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Chairman Director/Board Member Founder | |
Castle Creek Biosciences, Inc.
 Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | Biotechnology | Founder Director/Board Member Director/Board Member | |
Recludix Pharma, Inc.
 Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Recludix Pharma, Inc. is a biotechnology company that develops platform approaches to discover potent and selective inhibitors of challenging protein targets. The company is based in San Diego, CA. The company was founded by Brian Hodous, Nicholas B. Lydon, Patrick P. Zarrinkar, Daniel K. Treiber. Nancy C. Whiting has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member Chairman |
Estadísticas
Internacional
| Estados Unidos | 35 |
| Dinamarca | 6 |
| Reino Unido | 4 |
| Francia | 4 |
| Suiza | 4 |
Sectorial
| Health Technology | 32 |
| Consumer Services | 10 |
| Commercial Services | 6 |
| Finance | 4 |
| Miscellaneous | 2 |
Operativa
| Director/Board Member | 583 |
| Corporate Officer/Principal | 213 |
| Independent Dir/Board Member | 175 |
| Chairman | 105 |
| Chief Tech/Sci/R&D Officer | 82 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Daniel Bradbury | 45 |
| Göran Albert Ando | 44 |
| Jonathan Silverstein | 42 |
| Antonio Gracias | 42 |
| Patrick Heron | 42 |
| Stephen P. Squinto | 40 |
| Thomas Woiwode | 39 |
| Jack Nielsen | 38 |
| Tadataka Yamada | 36 |
| Jeffrey Aronin | 35 |
| Liam Ratcliffe | 32 |
| Clarence Machado | 29 |
| Steven Holtzman | 28 |
| William Burns | 27 |
| Chahra Khaoua Epouse Louafi | 26 |
- Bolsa de valores
- Insiders
- Sandipkumar S. Kapadia
- Conexiones Empresas
